Medical device licence · 86625 · Class 2
PALAXPRESS ULTRA
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed July 13, 2011; ended October 13, 2022. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 86625
- Licence holder
- Kulzer GmbhSouth Bend, IN, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- System
- First licensed
- July 13, 2011
- Ended
- October 13, 2022
- Devices covered
- 13
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- PALAXPRESS ULTRA LIGHT LIQUID
- PALAXPRESS ULTRA POWDER CLEAR
- PALAXPRESS ULTRA POWDER DARK PINK
- PALAXPRESS ULTRA POWDER LIGHT PINK
- PALAXPRESS ULTRA POWDER LIGHT REDDISH PINK
- PALAXPRESS ULTRA POWDER PINK
- PALAXPRESS ULTRA POWDER PINK LINE
- PALAXPRESS ULTRA POWDER PINK LIVE
- PALAXPRESS ULTRA POWDER PINK OPAQUE
- PALAXPRESS ULTRA POWDER PINK VEINED
- PALAXPRESS ULTRA POWDER R50 VEINED
- PALAXPRESS ULTRA POWDER R50M
- PALAXPRESS ULTRA POWDER SHADE 200
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.